Equillium EQ 深 沪
交易中 10-08 11:04:45 美东时间
1.36
-0.030
-2.16%
华盛通- 最 高1.41
- 今 开1.41
- 成交量 12.38万股
- 最 低 1.34
- 昨 收 1.39
- 总市值 8623.50万
- 52周最高 3.54
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 0.7562
- 委 比 -16.01%
- 总股本 6340.81万
- 历史最高 27.05
- 量 比 1.07
- 振 幅 5.04%
- 历史最低 0.27
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Equillium announced regulatory approval for its Phase 1 trial of EQ504 in Australia, aiming to begin dosing healthy participants by early November 2026. The randomized, double-blind, placebo-controlled study will assess safety, tolerability, pharmacokinetics, and pharmacodynamics of EQ504. EQ504, a potent AhR modulator, targets autoimmune and inflammatory disorders, particularly ulcerative colitis, by reducing inflammation and promoting mucosal h...
10-05 20:05
Equillium Announces Poster Presentations at the 7th International AHR Conference
<p>Equillium announced new preclinical data on EQ504, highlighting its effects on epithelial barrier repair and immune regulation. Presented at the 7th International AHR Conference, the findings demonstrate EQ504's potential for treating ulcerative colitis through selective AhR modulation. The studies, titled "Selective AhR Activation Suppresses Epithelial Chemokine Production and Promotes Barrier Repair Responses in Translational Models of Ulcer...
09-29 20:05
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target
Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
09-05 01:46
Equillium shares are trading higher after the company reported better-than-expected Q2 EPS results.
Equillium shares are trading higher after the company reported better-than-expected Q2 EPS results.
08-15 02:40
Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-14 10:30
美股大行评级 | 花旗上调苹果、西部数据、希捷科技、超微电脑等目标价；高盛上调蔚来"买入"评级，目标价7美元
今日重点评级关注：HC Wainwright & Co.：维持艾吉纳斯"买入"评级，目标价从23美元升至30美元；富国银行：上调Q32 Bio评级至"超配"，目标价66美元
07-14 11:36
Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $20.
07-13 17:38
Equillium Shareholders Approve Reverse Split and Capital Changes
Equillium ( ($EQ) ) has shared an announcement. On May 28, 2026, Equillium, Inc...
05-30 04:51
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target
Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
05-29 01:32
